# Fulvestrant in Treating Patients With Recurrent Prostate Cancer

> **NCT00217464** · PHASE2 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 17 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** fulvestrant

## Key facts

- **NCT ID:** NCT00217464
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2010-02
- **Final completion:** 2010-03
- **Target enrollment:** 17 (ACTUAL)
- **Why stopped:** Closed for futility
- **Last updated:** 2015-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217464, "Fulvestrant in Treating Patients With Recurrent Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00217464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*